These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 35483535)
1. Feasibility of hepatitis B elimination in high-income countries with ongoing immigration. Tian F; Feld JJ; Feng Z; Sander B; Wong WWL J Hepatol; 2022 Oct; 77(4):947-956. PubMed ID: 35483535 [TBL] [Abstract][Full Text] [Related]
2. Impact of the national hepatitis B immunization program in China: a modeling study. Liu Z; Li M; Hutton DW; Wagner AL; Yao Y; Zhu W; Cao L; Tang S; Pan J; Wang Y; Zhao Q; Ren H; Wang Y; Wang W Infect Dis Poverty; 2022 Oct; 11(1):106. PubMed ID: 36221140 [TBL] [Abstract][Full Text] [Related]
3. Feasibility of hepatitis C elimination by screening and treatment alone in high-income countries. Tian F; Forouzannia F; Feng Z; Biondi MJ; Mendlowitz AB; Feld JJ; Sander B; Wong WWL Hepatology; 2024 Aug; 80(2):440-450. PubMed ID: 38478751 [TBL] [Abstract][Full Text] [Related]
4. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china. Zhao S; Xu Z; Lu Y Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354 [TBL] [Abstract][Full Text] [Related]
5. The current and future burden of hepatitis B in Switzerland: a modelling study. Negro F; Müllhaupt B; Semela D; Blach S; Bruggmann P; De Gottardi A; Dufour JF; Fraga M; Galante A; Razavi H; Vieira Barbosa J; Razavi-Shearer D Swiss Med Wkly; 2023 Jun; 153():40086. PubMed ID: 37410921 [TBL] [Abstract][Full Text] [Related]
6. Moving towards hepatitis B elimination in Gulf Health Council states: From commitment to action. Al Awaidy ST; Ezzikouri S J Infect Public Health; 2020 Feb; 13(2):221-227. PubMed ID: 31445879 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B infection and immunity in migrant children and pregnant persons in Europe: a systematic review and meta-analysis. Hobart C; Pescarini JM; Evans L; Adil HS; Adil ST; Deal A; Carter J; Matthews PC; Hargreaves S; Sanchez Clemente N J Travel Med; 2024 Aug; 31(6):. PubMed ID: 38990201 [TBL] [Abstract][Full Text] [Related]
8. Requirements for global elimination of hepatitis B: a modelling study. Nayagam S; Thursz M; Sicuri E; Conteh L; Wiktor S; Low-Beer D; Hallett TB Lancet Infect Dis; 2016 Dec; 16(12):1399-1408. PubMed ID: 27638356 [TBL] [Abstract][Full Text] [Related]
9. The epidemiology of hepatitis B virus infection in Korea. Yim SY; Kim JH Korean J Intern Med; 2019 Sep; 34(5):945-953. PubMed ID: 30919608 [TBL] [Abstract][Full Text] [Related]
10. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217 [TBL] [Abstract][Full Text] [Related]
11. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Polaris Observatory Collaborators Lancet Gastroenterol Hepatol; 2023 Oct; 8(10):879-907. PubMed ID: 37517414 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B vaccination and prevention of hepatocellular carcinoma. Kao JH Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252 [TBL] [Abstract][Full Text] [Related]
13. NIH consensus development statement on management of hepatitis B. Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020 [TBL] [Abstract][Full Text] [Related]
14. Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study. Shimakawa Y; Veillon P; Birguel J; Pivert A; Sauvage V; Guillou-Guillemette HL; Roger S; Njouom R; Ducancelle A; Amta P; Huraux JM; Adoukara JP; Lunel-Fabiani F Lancet Glob Health; 2022 Apr; 10(4):e521-e529. PubMed ID: 35183302 [TBL] [Abstract][Full Text] [Related]
15. [Facilitating the continuous decline on the incidence rates of hepatitis B and liver cancer through cutting off the mother-to-child viral transmission, based on the "prevention first" strategy, in China]. Yu SZ Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Dec; 40(12):1650-1653. PubMed ID: 32062932 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccination in children: the Taiwan experience. Ni YH; Chen DS Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181 [TBL] [Abstract][Full Text] [Related]
17. [Development of Markov models for economics evaluation of strategies on hepatitis B vaccination and population-based antiviral treatment in China]. Yang PC; Zhang SX; Sun PP; Cai YL; Lin Y; Zou YH Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):845-851. PubMed ID: 28738454 [No Abstract] [Full Text] [Related]
18. Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting. Le LV; Blach S; Rewari B; Chan P; Fuqiang C; Ishikawa N; Sharma M; Mangadan-Konath N; Razavi H; Low-Beer D; Razavi-Shearer D Liver Int; 2022 Aug; 42(9):1930-1934. PubMed ID: 34894047 [TBL] [Abstract][Full Text] [Related]
19. Hospitalization related to chronic hepatitis B and C in recent immigrants in Canada: An immigration administrative data-linked, population-based cohort study. Ng E; Quinlan J; Giovinazzo G; Syoufi M; Massenat DE; Sanmartin C; Cooper C Health Rep; 2022 Jun; 33(6):30-45. PubMed ID: 35876614 [TBL] [Abstract][Full Text] [Related]
20. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Hsu YC; Huang DQ; Nguyen MH Nat Rev Gastroenterol Hepatol; 2023 Aug; 20(8):524-537. PubMed ID: 37024566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]